Characterization of Microbiota in Cancerous Lung and the Contralateral Non-Cancerous Lung Within Lung Cancer Patients

od Zhuo, Minglei, An, Tongtong, Zhang, Chaoting, Wang, Ziping
izdano v Front Oncol (2020)

Programmed cell death‐ligand 1 (PD‐L1) expression and fibroblast growth factor receptor 1 (FGFR1) amplification in stage III/IV lung squamous cell carcinoma (SQC)

od Guo, Qinxiang, Sun, Yu, Yu, Sifan, Bai, Hua, Zhao, Jun, Zhuo, Minglei, Wang, Jie
izdano v Thorac Cancer (2016)

Correlation among genetic variations of c-MET in Chinese patients with non-small cell lung cancer

od Duan, Jianchun, Yang, Xiaodan, Zhao, Jun, Zhuo, Minglei, Wang, Zhijie, An, Tongtong, Bai, Hua, Wang, Jie
izdano v Oncotarget (2017)

Epidermal growth factor receptor variant III mutation in Chinese patients with squamous cell cancer of the lung

od Duan, Jianchun, Wang, Zhijie, Bai, Hua, An, Tongtong, Zhuo, Minglei, Wu, Meina, Wang, Yuyan, Yang, Lu, Wang, Jie
izdano v Thorac Cancer (2015)

A phase I study of nimotuzumab plus docetaxel in chemotherapy-refractory/resistant patients with advanced non-small-cell lung cancer

od Zhao, Jun, Zhuo, Minglei, Wang, Zhijie, Duan, Jianchun, Wang, Yuyan, Wang, Shuhang, An, Tongtong, Wu, Meina, Wang, Jie
izdano v Chin J Cancer Res (2016)

Analysis of EGFR mutation status in tissue and plasma for predicting response to EGFR-TKIs in advanced non-small-cell lung cancer

od Wang, Yuyan, Duan, Jianchun, Chen, Hanxiao, Bai, Hua, An, Tongtong, Zhao, Jun, Wang, Zhijie, Zhuo, Minglei, Wang, Shuhang, Wang, Jie
izdano v Oncol Lett (2017)

Efficacy and safety of weekly intravenous nanoparticle albumin‐bound paclitaxel for non‐small cell lung cancer patients who have failed at least two prior systemic treatments

od Duan, Jianchun, Hao, Yueqin, Wan, Rui, Yu, Sifan, Bai, Hua, An, Tongtong, Zhao, Jun, Wang, Zhijie, Zhuo, Minglei, Wang, Jie
izdano v Thorac Cancer (2017)

Efficacy and Safety of PD-1/PD-L1 Inhibitors Plus Chemotherapy Versus PD-1/PD-L1 Inhibitors in Advanced Non-Small Cell Lung Cancer: A Network Analysis of Randomized Controlled Tria...

od Li, Xiang, Yan, Shi, Yang, Jichun, Wang, Yaqi, Lv, Chao, Li, Shaolei, Zhao, Jun, Yang, Yue, Zhuo, Minglei, Wu, Nan
izdano v Front Oncol (2021)

Detection and Clinical Significance of Intratumoral EGFR Mutational Heterogeneity in Chinese Patients with Advanced Non-Small Cell Lung Cancer

od Bai, Hua, Wang, Zhijie, Wang, Yuyan, Zhuo, Minglei, Zhou, Qinghua, Duan, Jianchun, Yang, Lu, Wu, Meina, An, Tongtong, Zhao, Jun, Wang, Jie
Izdano 2013

Quantification of mutant alleles in circulating tumor DNA can predict survival in lung cancer

od Yang, Xue, Zhuo, Minglei, Ye, Xin, Bai, Hua, Wang, Zhijie, Sun, Yun, Zhao, Jun, An, Tongtong, Duan, Jianchun, Wu, Meina, Wang, Jie
izdano v Oncotarget (2016)

Clinical Characteristics and Outcomes of Patients With Primary Mediastinal Germ Cell Tumors: A Single-Center Experience

od Wang, Lu, Zhao, Jun, An, Tongtong, Wang, Yuyan, Zhuo, Minglei, Wu, Meina, Wang, Ziping, Li, Jianjie, Yang, Xue, Chen, Hanxiao, Zhong, Jia
izdano v Front Oncol (2020)

Alterations in EGFR and Related Genes following Neo-Adjuvant Chemotherapy in Chinese Patients with Non-Small Cell Lung Cancer

od Wang, Shuhang, An, Tongtong, Duan, Jianchun, Zhang, Lijian, Wu, Meina, Zhou, Qinghua, Chen, Jinfeng, Zhuo, Minglei, Yang, Lu, Wang, Yuyan, Bai, Hua, Wang, Jie
Izdano 2013

Quantification and Dynamic Monitoring of EGFR T790M in Plasma Cell-Free DNA by Digital PCR for Prognosis of EGFR-TKI Treatment in Advanced NSCLC

od Wang, Zhijie, Chen, Rui, Wang, Shuhang, Zhong, Jia, Wu, Meina, Zhao, Jun, Duan, Jianchun, Zhuo, Minglei, An, Tongtong, Wang, Yuyan, Bai, Hua, Wang, Jie
izdano v PLoS One (2014)

Identification of plasma microRNA profiles for primary resistance to EGFR-TKIs in advanced non-small cell lung cancer (NSCLC) patients with EGFR activating mutation

od Wang, Shuhang, Su, Xiaomei, Bai, Hua, Zhao, Jun, Duan, Jianchun, An, Tongtong, Zhuo, Minglei, Wang, Zhijie, Wu, Meina, Li, Zhenxiang, Zhu, Jian, Wang, Jie
izdano v J Hematol Oncol (2015)

DNA Methylation status of Wnt antagonist SFRP5 can predict the response to the EGFR-tyrosine kinase inhibitor therapy in non-small cell lung cancer

od Zhu, Jian, Wang, Yuyan, Duan, Jianchun, Bai, Hua, Wang, Zhijie, Wei, Lai, Zhao, Jun, Zhuo, Minglei, Wang, Shuhang, Yang, Lu, An, Tongtong, Wu, Meina, Wang, Jie
Izdano 2012

Patients harboring epidermal growth factor receptor (EGFR) double mutations had a lower objective response rate than those with a single mutation in non-small cell lung cancer when...

od Wei, Zhigang, An, Tongtong, Wang, Zhijie, Chen, Keneng, Bai, Hua, Zhu, Guangying, Duan, Jianchun, Wu, Meina, Yang, Lu, Zhuo, Minglei, Wang, Yuyan, Liu, Xuyi, Wang, Jie
izdano v Thorac Cancer (2014)

Retrospective analysis of the effectiveness and tolerability of nab‐paclitaxel in Chinese elderly patients with advanced non‐small‐cell lung carcinoma

od Wang, Shuhang, Liang, Qiuping, Chi, Yujia, Zhuo, Minglei, An, Tongtong, Duan, Jianchun, Wang, Zhijie, Wang, Yuyan, Zhong, Jia, Yang, Xue, Chen, Hanxiao, Wang, Jie, Zhao, Jun
izdano v Thorac Cancer (2020)

Optimal first‐line treatment for advanced thymic carcinoma

od Yang, Xue, Zhuo, Minglei, Shi, Anhui, Yang, Shengnan, Wang, Ziping, Wu, Meina, An, Tongtong, Wang, Yuyan, Li, Jianjie, Zhong, Jia, Chen, Hanxiao, Jia, Bo, Dong, Zhi, Zhao, Jun
izdano v Thorac Cancer (2019)

Efficacy and safety of pemetrexed maintenance chemotherapy for advanced non-small cell lung cancer in a real-world setting

od Li, Jianjie, Chi, Yujia, Cao, Guang, Zhao, Jun, An, Tongtong, Wu, Meina, Wang, Yuyan, Zhuo, Minglei, Yang, Xue, Jia, Bo, Chen, Hanxiao, Wang, Jingjing, Zhai, Xiaoyu, Wang, Ziping
izdano v J Thorac Dis (2021)

Efficacy and Safety of Combination Treatment With Apatinib and Osimertinib After Osimertinib Resistance in Epidermal Growth Factor Receptor-Mutant Non-small Cell Lung Carcinoma—A R...

od Yang, Xue, Xia, Yang, Xu, Liyan, Liang, Li, Zhuo, Minglei, Wu, Meina, An, Tongtong, Wang, Ziping, Wang, Yuyan, Li, Jianjie, Zhong, Jia, Chen, Hanxiao, Jia, Bo, Wang, Jingjing, Zhao, Jun
izdano v Front Mol Biosci (2021)